HAMILTON LANE ADVISORS LLC Inhibikase Therapeutics, Inc. Transaction History

HAMILTON LANE ADVISORS LLC portfolio value:

$151,000
portfolio value

HAMILTON LANE ADVISORS LLC quarter portfolio value change:

+22.54%
quarter

Inhibikase Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 28K $0.91 165.63K
Q2 2022 share 0.00% 0 shares -122K $0.74 165.63K
Q1 2022 share Increase 0.00% 165.63K shares 245K $1.48 165.63K